Stocks
Anika Therapeutics (ANIK) EBITDA margin US GAAP (year values) |
||||||||
| 2021 | 2022 | 2023 | 2023 | 2023 | LTM ? | |||
| EBITDA margin, % | ? | 1.77% | -3.14% | -11.0% | 1.51% | -6.73% | -31.7% | |
| Changes by years, y/y, % | +2pp | -5pp | -8pp | +13pp | -8pp | |||
Anika Therapeutics. EBITDA margin, %
Anika Therapeutics. EBITDA margin, changes, pp
Anika Therapeutics (ANIK) EBITDA margin US GAAP (quarter values) |
||||||||
| 2023Q4 | 2024Q1 | 2024Q2 | 2024Q3 | 2024Q3 | LTM ? | |||
| EBITDA margin, % | ? | 4.65% | -4.62% | 5.29% | -66.0% | -65.6% | -31.7% | |
| Changes by years, y/y, % | +21pp | +19pp | +5pp | -56pp | -56pp | |||
| Changes by quarters, q/q, % | +0pp | -9pp | +10pp | -71pp | +0pp | |||
